Navigation Links
Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
Date:1/24/2008

mic, regulatory and political conditions affecting the biotechnology and pharmaceutical industry; and the other risks and uncertainties discussed in this announcement and in Genaera's filings with the U.S. Securities and Exchange Commission, all of which are available from the Commission in its EDGAR database at http://www.sec.gov as well as other sources. You are encouraged to read these reports. Given the uncertainties affecting development stage pharmaceutical companies, you are cautioned not to place undue reliance on any such forward-looking statements, any of which may turn out to be wrong due to inaccurate assumptions, unknown risks, uncertainties or other factors. Genaera does not intend (and it is not obligated) to publicly update, revise or correct these forward-looking statements or the risk factors that may relate thereto.


'/>"/>
SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
3. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
6. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
7. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
8. CEL-SCI Corporation Releases Letter to Shareholders
9. Alfacell Corporation to Present at UBS Global Life Sciences Conference
10. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
11. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...twonewtherapiesforNon-Hodgkin,sLymphomas(NHL),theN...mab(Azerra(TM),GlaxoSmithKline)asatherapyoptionfor...depsin(Istodax(R),GloucesterPharmaceuticals)asasug...oma(CTCL). ,, FORTWASHINGTON,Pa.,Nov.23/PRNewsw...theNationalComprehensiveCancerNetwork( NCCN )toupd...
(Date:11/23/2009)...--Reportlinker.comannouncesthatanewmarketresearchr...isposables-AWorldMarketReview ,, http://www....-A-World-Market-Review.html#utm_source=prnewswire&...,, Globalgeneralanesthesiadisposablesmarketisch...siderablerisewitnessedingeneralsurgicalprocedures,...
(Date:11/23/2009)...PRNewswire-FirstCall/-- LexiconPharmaceuticals,Inc...omitsPhase2clinicalstudywith LX1031 inpatientswith...resentedatGASTRO2009inLondonthisweek.Resultsfromth...toms,willbepresentedbyDr. PhilipM.Brown ,Lexicon,s...r25,2009at2:30pmlocaltimeatthesessionentitled,"The...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 1Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 2Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 3Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 4Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 1Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 2One of Womens Best Kept Secrets is Now Available in the Mens Department 48145 1One of Womens Best Kept Secrets is Now Available in the Mens Department 48145 2
...il 21 A new study funded by,Health Canada and oth...etween dietary consumption of the omega-3 DHA* and... supervised by Universite Laval,researchers and pu...consumed during the last months of pregnancy boost...ment., The research team reached its conclusion b...
...s offer revolutionary STARscanner, STARband(R) ...April 21 Mother Claudia Aguilar had been,concerne...e he was born.,Doctors had to utilize forceps to a...skull. Aguilar,s pediatrician told her the bumps m...n,s six month checkup, the bumps were,still presen...
Other Medicine Technology:Pregnant Women Need Omega-3 to Boost Infant Development 2STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children 2STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children 3STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children 4STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children 5
(Date:11/23/2009)...wswire/--Hazelden,theinternationallyrenownednonpro...rshipteamforitsnewrecoverycenterinNaples,Florida.H...lateMarch2010,andwillinitiallyprovideaddictiontrea...andoutpatientservices. ,, MichaelDemask,Ph.D.,w...aples,withBrendaIliff,M.A.,L.A.D.C.,asclinicaldire...
(Date:11/23/2009)...mSupportsFutureLeadersinSTEMFields ,, Scholar...n ceS c holars.org ,, WASHINGTON,No...ountusin.Withourcommunity,foundation,andcorporatep...ate,"saidAdolphP.Falcon,SeniorVicePresidentoftheNa...teHousemeetingtodaywherePresidentObamaannouncedthe...
(Date:11/23/2009)...re/--CortivaInstituteTucsonwillhostanIntroductiont...theschool,s6390EastBroadwayBlvd.location,whichwill...icebasicmassagestrokes. ,, "Massagetherapyisagr...longwithit,"saidJoannMcMaster,presidentofCortivaIn...or,s2009-2010OccupationalOutlookHandbookstatesthat...
(Date:11/23/2009)...Howistheeconomyaffectingpeople,swellness?According...ss&theEconomy,theeconomyismakinguscollectively...exerciseanddiettoonethatismoreinwardlyfocusedonada...tdramaticfindingwasthechangeinconsumers,definition...thandwellbeingtotoday,smorerelevantconcernsaboutad...
(Date:11/23/2009)...errors self-reported by American surgeons are stro... findings appear today in the online edition of A...ded collaborators from Johns Hopkins and the Ameri...l study, nearly 9 percent of U.S. surgeons respond...hs prior to being surveyed. Over 70 percent attrib...
Breaking Medicine News(10 mins):Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:Burnout and mental distress strongly related to errors by US surgeons 2
... Although the median price ...ively stable since January, 2009 (1 April, 09 Bloo...ast year, and the NZ dollar decline of between 16 ...erty in the South Island. , ...
... Medtral New Zealand offers...ican patients seeking a viable, safe alternative t... Long Beach, CA (PRWEB) April 8, 2009 --...ry as he has no health insurance. At the same time...
...Multiple, anatomically distinct lung cancer tumors...ccording to a retrospective analysis of patient tu...of the Journal of the National Cancer Institute. ...n appearance, it has been unclear whether they ari...
...ouncil Will Hear Public Comments on Comparative Ef...t , , ROCKVILLE, Md., April 7 The Federal Coordi...rch will hold a public listening session on April ...es. , , "The Obama Administration is committed to...
...h-intensity early treatment may lead to more inter...Y, April 7 (HealthDay News) -- More intensive trea...early bladder cancer doesn,t appear to improve pat...he average cost of care for patients who received ...
...Modern moms and dads snap thousands of photos, rec...o crawl. Until now, this frenzy of activity could ...ing their child,s health and developmental progres...letters, and at the same time tracks a child,s dev...
Other Medicine News:Health News:New Zealand Beach Front Property Offers Global Currency Rate Bargains 2Health News:A New Zealand Experience That Improves Lives: Arizona Man Finds Affordable, Quality Healthcare and Freedom From Constant Hip Pain on Recent Trip 2Health News:A New Zealand Experience That Improves Lives: Arizona Man Finds Affordable, Quality Healthcare and Freedom From Constant Hip Pain on Recent Trip 3Health News:Multifocal lung cancers appear to originate from single cancer clone 2Health News:Federal Coordinating Council on Comparative Effectiveness Research to Hold Public Listening Session in Washington, DC 2Health News:Intensive Early Treatment Doesn't Help Bladder Cancer Survival 2Health News:Digital album puts focus on kids' health 2Health News:Digital album puts focus on kids' health 3
...xperience the finest surgical-quality loupes avail...andard for innovative optical design, combining su...livering optimum performance with maximum comfort,...al professionals worldwide. All SheerVision loupes...
...xperience the finest surgical-quality loupes avail...andard for innovative optical design, combining su...ivering optimum performance with maximum comfort, ...l professionals worldwide. Make both a professiona...
...hese award-winning surgical loupes from SheerVisio...resolution optics combined with light-weight comfo...s weight as little as 1.5 ounces when included wit...in either a flip-up or through-the-lens (TTL) desi...
...heerVision is now the first manufacturer to offer ...he wearer. These next generation loupes feature ex...tra-lightweight design, and are multi-coated lens ...With SheerVision's proprietary SureFit system - yo...
Medicine Products: